BOOK
Textbook of Paediatric Emergency Medicine
Peter Cameron | Gary J. Browne | Biswadev Mitra | Stuart Dalziel | Simon Craig
(2018)
Additional Information
Book Details
Abstract
It is now more than ten years since the publication of the first edition of Textbook of Paediatric Emergency Medicine and interest in this specialty continues to grow at a local and international level. Paediatric emergency medicine can be a challenging and difficult area for doctors. Children cannot always communicate their problems verbally, while parents are anxious and the possibility of a missed diagnosis is ever present. Although the principles in managing paediatric patients are the same as adults there are significant differences in patterns of illness and response. In addition, the therapies available vary widely between adult and paediatric practice.
Textbook of Paediatric Emergency Medicine provides clear, concise and comprehensive coverage of all the major topics that present within paediatric emergency medicine. It offers a consensus approach to diagnosis and treatment, drawing on the latest evidence available. Short chapters with key point boxes allow for the quick and easy retrieval of information, essential when time is short.
This Third Edition captures the major changes in guidelines across the specialty in the assessment and management of paediatric patients, whilst refining established approaches to practice. The text reviews both new technologies and the better application of older techniques which have led to changes in practice. There are significant updates to the sections on resuscitation and trauma, the clinical applications of bedside ultrasound, analgesia and sedation. There is also a new focus on the teaching and research sections.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
IFC\r | ES1 | ||
Textbook of PAEDIATRIC EMERGENCY MEDICINE | i | ||
Textbook of PAEDIATRIC EMERGENCY MEDICINE | iii | ||
Copyright | iv | ||
Contents | v | ||
Preface to third edition | ix | ||
Preface to second edition | x | ||
Contributors | xi | ||
Acknowledgements | xvii | ||
1 -\rAPPROACH TO THEPAEDIATRIC PATIENT | 1 | ||
1.1 Approach to the paediatric patient | 1 | ||
Introduction | 1 | ||
Who sees paediatric emergencies? | 1 | ||
Identifying the potentially sick child | 1 | ||
Children with fever | 2 | ||
Evolving illness in children | 2 | ||
The environment | 2 | ||
Triage | 3 | ||
Front loading care | 3 | ||
The paediatric approach | 3 | ||
Gaining rapport | 3 | ||
Age appropriate | 4 | ||
Developmentally appropriate | 4 | ||
Parental involvement | 4 | ||
History | 4 | ||
Critically ill child | 4 | ||
Parental issues | 4 | ||
Child-specific issues | 4 | ||
Examination | 5 | ||
Age appropriate | 5 | ||
Gentle, distraction, painful last | 5 | ||
Improvise | 5 | ||
Observation | 6 | ||
Observational variables | 6 | ||
Observing breathing | 6 | ||
Confounders | 6 | ||
Re-evaluate | 6 | ||
Respiratory examination | 6 | ||
Abdominal examination | 6 | ||
ENT last | 6 | ||
When to investigate | 7 | ||
The parents | 7 | ||
Managing the parents | 7 | ||
Communication issues | 7 | ||
Management of febrile children | 7 | ||
Reasonable expectations | 8 | ||
Decision making | 8 | ||
When to admit | 8 | ||
Factors influencing disposition | 8 | ||
Continuity of care | 8 | ||
Observation ward | 8 | ||
Making a diagnosis | 8 | ||
The role of the GP in paediatric emergency management | 9 | ||
Introduction | 9 | ||
Management prior to hospital care | 9 | ||
Management after hospital care | 9 | ||
Developmental milestones | 10 | ||
Growth | 10 | ||
Immunisation | 10 | ||
Vital signs | 10 | ||
REFLECTION ON THE PRACTICE OF PAEDIATRIC EMERGENCY | 10 | ||
Acknowledgements | 11 | ||
1.2 Common chronic paediatric conditions | 12 | ||
2 - Resuscitation\r | 19 | ||
2.1 Paediatric cardiopulmonary arrest | 19 | ||
Preventing cardiac arrest | 20 | ||
Outcome | 20 | ||
Differences compared to adults | 20 | ||
Development of resuscitation guidelines | 20 | ||
Ethics of paediatric resuscitation | 20 | ||
Termination of resuscitative efforts | 21 | ||
Non-initiation of resuscitative efforts | 22 | ||
Non-accidental injury | 22 | ||
Organ donation | 22 | ||
Death certificates, notification to the coroner and other legal issues | 22 | ||
Child death – follow-up of family | 22 | ||
References | 22 | ||
2.2 Paediatric basic life support | 23 | ||
Introduction | 23 | ||
Paediatric versus adult basiclife support | 23 | ||
Aetiology of arrests | 23 | ||
Anatomy and physiology | 23 | ||
Basic life support techniquesand age | 23 | ||
Preparation and equipment | 23 | ||
Basic life support sequence | 23 | ||
A ‘DRSABC’ approach | 23 | ||
Duration of basic life support inthe field | 26 | ||
Precautions and complications | 26 | ||
Relief of foreign body airwayobstruction | 26 | ||
Foreign body airway obstructionmanagement: conscious patient witheffective cough | 26 | ||
Foreign body airway obstruction:consciouspatient with ineffectivecough | 26 | ||
Foreign body airway obstructionmanagement: unconscious patient | 26 | ||
2.3 Paediatric advanced life support | 27 | ||
Introduction | 27 | ||
Definition of advanced life support | 27 | ||
Diagnosing cardiac arrest | 27 | ||
Epidemiology | 28 | ||
Oxygen, ventilation and advancedairway support | 28 | ||
Oxygen | 28 | ||
Nasal prongs/nasal catheters | 28 | ||
High flow nasal cannula | 28 | ||
Oxygen masks | 28 | ||
Head boxes and incubators | 28 | ||
Ventilation | 28 | ||
Self-inflating bags | 29 | ||
T-piece devices | 29 | ||
Flow-inflating bags | 29 | ||
Rates and ratios of external cardiaccompression and ventilation inadvanced life support | 29 | ||
Advanced airway support | 29 | ||
Tracheal intubation | 29 | ||
Endotracheal tube size (Table 2.3.1) | 30 | ||
Depth of tube insertion (see Table 2.3.1) | 30 | ||
Laryngeal mask airway | 30 | ||
Management of the difficult airway | 30 | ||
Causes of a difficult airway | 31 | ||
Predicting a difficult airway | 31 | ||
Difficult intubation | 31 | ||
Endotracheal intubation techniqueoptimisation | 31 | ||
Failed intubation | 31 | ||
Emergency surgical airway techniques | 32 | ||
Monitoring | 32 | ||
Oximetry | 32 | ||
Expired CO2 detection | 32 | ||
Electrocardiograph | 32 | ||
Vascular access | 32 | ||
Peripheral venous cannulation | 32 | ||
Intraosseous access | 33 | ||
Central venous cannulation | 33 | ||
Endotracheal route | 33 | ||
Other techniques | 33 | ||
Fluid therapy | 33 | ||
Resuscitation drugs | 33 | ||
Direct current shock | 34 | ||
Management of pulselessarrhythmias (Fig. 2.3.1) | 35 | ||
Asystole/severe pulseless bradycardia | 35 | ||
Pulseless electrical activity andelectromechanical dissociation | 35 | ||
Ventricular fibrillation and pulselessventricular tachycardia | 35 | ||
Management of pulsatiledysrhythmias | 36 | ||
Bradysrhythmias | 36 | ||
Tachydysrhythmias (Fig. 2.3.2) | 36 | ||
Pulsatile ventricular tachycardia | 36 | ||
Supraventricular tachycardia | 36 | ||
Wide QRS complex supraventriculartachycardia | 37 | ||
Post-resuscitation management(Box 2.3.1) | 37 | ||
Cessation of cardiopulmonaryresuscitation | 37 | ||
References | 37 | ||
2.4 Paediatric resuscitation in specificcircumstances | 38 | ||
Avoiding cardiac arrest duringcritical care management | 38 | ||
Anaphylaxis | 38 | ||
Asthma | 38 | ||
Drowning | 39 | ||
Traumatic cardiac arrest | 39 | ||
Toxicological emergencies | 39 | ||
Intravenous lipid emulsion | 39 | ||
Drug-induced asystole | 39 | ||
Envenomation | 40 | ||
Snake envenomation (see Chapter 22.1,Envenomation) | 40 | ||
Marine envenomation | 40 | ||
Box jellyfish (Chironex Fleckeri ) | 40 | ||
References | 40 | ||
2.5 Shock | 40 | ||
Introduction | 40 | ||
Diagnosis and assessment | 41 | ||
Airway | 41 | ||
Breathing | 41 | ||
Circulation | 41 | ||
Heart rate | 41 | ||
Blood pressure | 41 | ||
Capillary refill | 41 | ||
Effects of circulatory inadequacyincluding neurological status | 41 | ||
Circulation | 42 | ||
Further management | 42 | ||
Hypovolaemia | 42 | ||
Septic shock | 42 | ||
Acute severe allergic reaction(anaphylaxis) | 42 | ||
Duct-dependent congenitalheart disease | 43 | ||
Heart failure | 43 | ||
Neurogenic shock | 43 | ||
Further reading | 43 | ||
2.6 Sepsis recognition and initial management | 43 | ||
Introduction | 43 | ||
Background | 44 | ||
Definition | 44 | ||
Aetiology | 44 | ||
Pathophysiology | 45 | ||
Diagnosis | 45 | ||
Initial emergency management(Fig. 2.6.1) | 45 | ||
Monitoring | 45 | ||
General supportive measures | 45 | ||
Intravenous access | 45 | ||
Initial blood tests | 45 | ||
Initial treatment | 45 | ||
Therapeutic targets | 45 | ||
Disposition | 45 | ||
References | 45 | ||
3 -\rNEONATAL EMERGENCIES | 47 | ||
3.1 The normal neonate | 47 | ||
Definition and introduction | 47 | ||
Immediately after birth | 47 | ||
The neonatal history | 47 | ||
The neonatal examination | 48 | ||
Common reasons for healthy neonates to present to the emergency department | 48 | ||
Feeding problems | 48 | ||
Crying (see Chapter 3.2, The crying infant) | 49 | ||
Vomiting and spilling | 49 | ||
Preventative advice | 49 | ||
Summary | 49 | ||
Further reading | 49 | ||
3.2 The crying infant | 50 | ||
Introduction | 50 | ||
Recurrent crying | 50 | ||
Colic | 50 | ||
Management | 50 | ||
Gastro-oesophageal reflux | 50 | ||
General advice | 50 | ||
Acute crying | 51 | ||
Assessment | 51 | ||
Examination | 51 | ||
Investigations | 51 | ||
Disposition | 51 | ||
References | 51 | ||
3.3 Neonatal Dermatology | 51 | ||
SKIN IN THE NEONATAL PERIOD | 51 | ||
Neonatal erythroderma (Fig. 3.3.1) | 52 | ||
Potential causes of erythroderma | 52 | ||
Investigations in erythroderma | 52 | ||
Management of the erythrodermic neonate | 52 | ||
Red scaly rashes | 53 | ||
Infantile seborrheic dermatitis/eczema | 53 | ||
Psoriasis | 53 | ||
Ichthyosis | 53 | ||
Neonatal lupus erythematosus(Fig. 3.3.2) | 53 | ||
Zinc deficiency/acrodermatitis enteropathica | 53 | ||
Langerhans cell histiocytosis (see Chapter 12.1, Dermatology)Tinea corporis | 53 | ||
Congenital syphilis | 53 | ||
Vesicles and blisters | 53 | ||
Herpes simplex | 53 | ||
Varicella | 53 | ||
Staphylococcus aureus | 54 | ||
Miliaria | 54 | ||
Epidermolysis bullosa | 54 | ||
Autoimmune blistering disease | 54 | ||
Pustular lesions | 55 | ||
Infection | 55 | ||
Neutropenia | 55 | ||
Neonatal pityrosporum folliculitis(Neonatal cephalic pustulosis)(Fig. 3.3.4) | 55 | ||
Erythema toxicum neonatorum (toxic erythema of the newborn) | 55 | ||
Transient neonatal pustular dermatosis | 55 | ||
Acropustulosis of infancy | 55 | ||
Eosinophilic pustular folliculitis (scalp) | 55 | ||
Milia and sebaceous gland hyperplasia | 55 | ||
Birthmarks | 55 | ||
Congenital melanocytic naevi | 55 | ||
Epidermal naevi | 55 | ||
Incontinentia pigmenti | 56 | ||
Pigmentary mosaicism | 56 | ||
Café au lait macules | 56 | ||
Blue/purple lesions | 56 | ||
Blueberry muffin syndrome (Fig. 3.3.5) | 56 | ||
Other important causes | 56 | ||
Vascular lesions in the neonatal period | 56 | ||
Cutis marmorata | 56 | ||
Harlequin colour change | 57 | ||
Salmon patch (naevus simplex, stork mark, angel’s kiss) | 57 | ||
Vascular anomalies | 57 | ||
3.4 Acute neonatal emergencies | 57 | ||
THE NEONATAL PERIOD | 57 | ||
Neonatal resuscitation (seeChapter 3.5) | 57 | ||
Assessment of the neonate | 57 | ||
The collapsed neonate | 58 | ||
Sepsis | 58 | ||
The neonate with vomiting | 60 | ||
Intestinal obstruction | 61 | ||
Lung parenchymal pathology | 63 | ||
Airway obstruction | 64 | ||
Non-pulmonary disease | 64 | ||
The neonate with prolonged jaundice | 64 | ||
3.5 Neonatal resuscitation | 66 | ||
Introduction | 66 | ||
Epidemiology | 66 | ||
Aetiology and pathophysiology | 66 | ||
Preparation | 67 | ||
Assessment at birth | 67 | ||
Ventilation | 67 | ||
Artificial ventilation | 67 | ||
Heart rate | 68 | ||
Compression technique | 68 | ||
Colour | 68 | ||
Muscle tone and reflex irritability | 68 | ||
Medications | 68 | ||
Vascular access | 68 | ||
Adrenaline | 69 | ||
Naloxone | 69 | ||
Dextrose | 69 | ||
Volume expansion | 69 | ||
Bicarbonate | 69 | ||
Specific resuscitation situations | 69 | ||
Premature neonate | 69 | ||
Meconium aspiration | 69 | ||
Congenital heart disease | 69 | ||
Post-resuscitation stabilisation | 70 | ||
Prognosis | 70 | ||
References | 71 | ||
Further reading | 71 | ||
4 - TRAUMA IN CHILDREN\r | 73 | ||
4.1 Introduction to paediatric trauma | 73 | ||
Prevalence | 73 | ||
Prevention | 73 | ||
Succinct treatment (salvage) | 74 | ||
Primary survey | 74 | ||
Paediatric differences | 74 | ||
Catastrophic external haemorrhage control | 74 | ||
A. Airway and cervical spine control | 75 | ||
B. Breathing and high flow oxygen | 75 | ||
C. Circulation and stop haemorrhage | 75 | ||
D. Disability | 76 | ||
E. Exposure and environment | 76 | ||
Other issues during initial stabilisation | 76 | ||
Early analgesia | 76 | ||
Continuous monitoring | 76 | ||
Psychological support of child and family members | 76 | ||
Secondary survey | 76 | ||
Definitive care and disposition | 76 | ||
Orthopaedic trauma | 76 | ||
Rehabilitation | 77 | ||
References | 77 | ||
4.2 Paediatric neurotrauma | 78 | ||
Introduction | 78 | ||
Epidemiology | 78 | ||
Pathophysiology | 78 | ||
Classification | 79 | ||
Mild traumatic brain injury (GCS 14 to 15) | 79 | ||
Moderate traumatic brain injury (GCS 9 to 13) | 79 | ||
Severe traumatic brain injury (GCS 8 or less) | 79 | ||
Assessment | 79 | ||
History | 79 | ||
Examination | 80 | ||
Glasgow Coma Scale | 80 | ||
Investigations | 80 | ||
Laboratory | 80 | ||
Radiological | 81 | ||
Management | 81 | ||
Spinal cord injury | 84 | ||
Supportive care | 84 | ||
Family considerations | 84 | ||
Disposition | 84 | ||
4.3 Spinal injury | 86 | ||
Introduction | 86 | ||
Developmental anatomy and physiology | 86 | ||
Initial assessment | 87 | ||
Spinal immobilisation | 87 | ||
Cervical spine injuries | 88 | ||
Mechanisms of injury | 88 | ||
Flexion | 88 | ||
Extension | 88 | ||
Rotation | 88 | ||
Vertical compression | 88 | ||
Clinical assessment | 88 | ||
Radiographic images | 88 | ||
Flexion and extension | 89 | ||
Computerised tomography | 89 | ||
Magnetic resonance imaging | 89 | ||
Radiographic evaluation | 89 | ||
Cervical spine clearance guidelines | 89 | ||
Atlantoaxial rotary subluxation | 90 | ||
Thoracic and lumbar spine injuries | 90 | ||
Mechanism of injury | 90 | ||
Clinical assessment | 90 | ||
Radiographic evaluation | 90 | ||
Management | 91 | ||
Spinal cord injury | 91 | ||
Spinal cord injury syndromes | 92 | ||
Clinical assessment | 92 | ||
Radiographic evaluation | 92 | ||
Treatment | 92 | ||
Spinal cord injury without radiographic abnormality | 92 | ||
16References | 93 | ||
4.4 Thoracic injuries in childhood | 94 | ||
Introduction3–6 | 94 | ||
Initial approach in the emergency department1,7,8 | 94 | ||
Chest wall injury9,10 | 95 | ||
Rib fractures | 95 | ||
Pulmonary injury11,12 | 95 | ||
Contusion | 95 | ||
Pneumothorax6,13,14 | 95 | ||
Tension pneumothorax | 95 | ||
Pulmonary lacerations 7 | 96 | ||
Haemothorax1,13,15 | 96 | ||
Tracheobronchial injuries1,14,15 | 96 | ||
Mediastinal injury1,7,13,15 | 96 | ||
Aortic transection | 96 | ||
Cardiac injuries16 | 97 | ||
Commotio cordis17,18 | 97 | ||
Penetrating cardiac trauma19 | 97 | ||
Diaphragmatic injury13,15,20 | 97 | ||
Oesophageal injury7 | 97 | ||
Emergency department thoracotomy19,21 | 97 | ||
4.5 Abdominal and pelvic trauma | 98 | ||
Introduction | 98 | ||
History | 99 | ||
Examination | 99 | ||
Investigations | 100 | ||
Laboratory | 100 | ||
Focused assessment by sonography for trauma | 100 | ||
Plain films | 100 | ||
Computed tomography scan | 100 | ||
Formal ultrasound | 100 | ||
General management | 100 | ||
Surgical issues | 101 | ||
Hollow viscus injuries | 101 | ||
Pancreatic and renal injuries | 102 | ||
Interventional radiology | 102 | ||
Penetrating trauma | 102 | ||
Pelvic fractures | 102 | ||
Disposition | 103 | ||
References | 103 | ||
4.6 Burns | 104 | ||
Introduction | 104 | ||
Pathophysiology | 104 | ||
Classification | 104 | ||
Superficial | 104 | ||
Partial thickness | 104 | ||
Full thickness | 105 | ||
History | 105 | ||
Examination | 105 | ||
Primary survey | 105 | ||
Evaluation of burn area | 105 | ||
Investigations | 106 | ||
Management | 106 | ||
Pre-hospital | 106 | ||
Emergency department | 106 | ||
Fluid resuscitation | 106 | ||
Management of burns (Box 4.6.1) | 107 | ||
Major burns | 107 | ||
Minor burns | 107 | ||
Superficial burns | 107 | ||
Electrical burns | 107 | ||
Introduction | 107 | ||
Clinical effects | 108 | ||
Management | 108 | ||
Specific issues | 108 | ||
Disposition | 108 | ||
Chemical burns | 108 | ||
Treatment | 108 | ||
Further reading | 108 | ||
4.7 Children in a disaster response | 109 | ||
Introduction | 109 | ||
Children in disaster situations | 109 | ||
Phases of disaster response | 109 | ||
4.8 Wound management | 110 | ||
Introduction | 111 | ||
Anatomy of the skin | 111 | ||
Pathophysiology of wound healing | 111 | ||
Wound infection | 111 | ||
Classification of wounds | 111 | ||
Evaluation of the patient with a laceration | 111 | ||
History | 111 | ||
Examination | 112 | ||
Investigation | 112 | ||
Treatment of wounds | 112 | ||
Wound anaesthesia | 112 | ||
Wound preparation and cleansing | 113 | ||
Antibiotic prophylaxis | 113 | ||
Wound closure | 114 | ||
Sutures | 114 | ||
Needles | 114 | ||
Suturing techniques | 115 | ||
Special suturing techniques | 116 | ||
Correction of dog ears | 116 | ||
Staples | 116 | ||
Tissue adhesives | 116 | ||
Skin tapes | 117 | ||
Post-wound-closure care | 117 | ||
Dressing and suture removal | 117 | ||
Immobilisation and drains | 117 | ||
Treatment of selected injuries | 118 | ||
Abrasions | 118 | ||
Eyelid lacerations | 118 | ||
Lip lacerations | 118 | ||
Tongue lacerations | 118 | ||
Fingertip amputation | 118 | ||
Nailbed lacerations | 119 | ||
Subungual haematoma | 119 | ||
Puncture wounds to the foot | 119 | ||
Bites | 119 | ||
Acknowledgement | 120 | ||
References | 120 | ||
5 -\rCARDIOVASCULAR | 121 | ||
5.1 Cardiovascular assessment and murmurs | 121 | ||
Introduction | 121 | ||
History | 121 | ||
Physical examination | 122 | ||
Chest X-ray | 122 | ||
Electrocardiography | 122 | ||
Atrial enlargement | 122 | ||
Ventricular enlargement | 122 | ||
The child with an asymptomatic murmur | 124 | ||
Pathological murmurs | 124 | ||
Disposition | 124 | ||
Further reading | 124 | ||
5.2 Chest pain | 125 | ||
Introduction | 125 | ||
Immediate approach | 125 | ||
General approach (Table 5.2.1) | 125 | ||
History | 125 | ||
Physical examination | 125 | ||
Investigations | 126 | ||
Summary | 126 | ||
References | 126 | ||
5.3 Syncope | 126 | ||
Introduction | 126 | ||
Aetiology | 127 | ||
Typical presentations | 127 | ||
Vasovagal syncope | 127 | ||
Breath-holding spells and reflexanoxic seizures | 127 | ||
Cardiac syncope | 127 | ||
Hypovolaemic states | 127 | ||
Seizures | 127 | ||
Hyperventilation and conversion syncope | 127 | ||
Clinical | 128 | ||
History | 128 | ||
Examination | 128 | ||
Investigations within theemergency department | 128 | ||
Further investigations of syncope | 129 | ||
Management of syncope within the emergency department | 129 | ||
Summary | 129 | ||
Further reading | 129 | ||
5.4 Cyanotic heart disease and tetralogy of Fallot spells | 130 | ||
Introduction | 130 | ||
Cyanotic congenital heart disease | 130 | ||
Clinical features2,3,5,6 | 130 | ||
Investigations | 130 | ||
Management2–6 | 131 | ||
Disposition | 131 | ||
TETRALOGY SPELLS | 131 | ||
Introduction3–6, 9–12 | 131 | ||
Investigations3–6 | 131 | ||
Laboratory | 132 | ||
ECG | 132 | ||
Chest X-ray | 132 | ||
Echocardiography | 132 | ||
Treatment3–6, 9–12 | 132 | ||
Disposition | 132 | ||
References | 132 | ||
Further reading | 132 | ||
5.5 Heart failure | 133 | ||
Definition | 133 | ||
Causes of congestive heart failure | 133 | ||
Clinical manifestations and investigations | 133 | ||
Presentation1–3 | 133 | ||
General features1–3 | 133 | ||
Staging4–9 | 133 | ||
Assessment | 133 | ||
Referral | 133 | ||
Management1–3, 10–14 | 134 | ||
Acute management | 134 | ||
Diuretics | 134 | ||
Angiotensin-converting enzyme inhibitors | 134 | ||
β-blockers | 134 | ||
Digoxin | 134 | ||
Levosimendan | 134 | ||
References | 134 | ||
5.6 Congenital heart disease | 135 | ||
Introduction | 135 | ||
Incidence | 135 | ||
Pathophysiology | 135 | ||
Undiagnosed congenital heart disease | 135 | ||
Findings that may indicate congenital heart disease | 135 | ||
Diagnostic approach | 135 | ||
Common presentations and initial management | 135 | ||
Neonate/infant | 135 | ||
Older child | 137 | ||
Early | 138 | ||
Late | 138 | ||
Congenital heart disease and intercurrent illness | 138 | ||
Dehydration – including gastroenteritis | 138 | ||
Respiratory disease | 138 | ||
Further reading | 138 | ||
5.7 Acute rheumatic fever | 139 | ||
Introduction | 139 | ||
Epidemiology | 139 | ||
Pathophysiology | 139 | ||
Diagnosis of acute rheumatic fever | 139 | ||
Clinical manifestations (historyand examination) | 139 | ||
Investigations | 140 | ||
Laboratory evidence of group A β-haemolytic streptococcal infection | 140 | ||
Differential diagnosis | 140 | ||
Treatment | 141 | ||
Acute management | 141 | ||
Symptomatic treatment of arthritis | 141 | ||
Treatment of carditis and control of heart failure | 141 | ||
Management of chorea | 141 | ||
Prevention and prophylaxis | 141 | ||
Prognosis | 141 | ||
References | 141 | ||
5.8 Infective endocarditis | 142 | ||
Introduction | 142 | ||
Epidemiology | 142 | ||
Pathophysiology | 142 | ||
Microbiology | 142 | ||
History | 142 | ||
Examination | 142 | ||
Modified Duke criteria | 143 | ||
Major criteria | 143 | ||
Minor criteria | 143 | ||
Investigations | 143 | ||
Laboratory | 143 | ||
Imaging | 143 | ||
Differential diagnosis | 143 | ||
Treatment | 143 | ||
Medical | 143 | ||
Surgical | 143 | ||
Prognosis | 143 | ||
Prevention | 143 | ||
11References | 144 | ||
5.9 Kawasaki disease | 144 | ||
Introduction | 144 | ||
Pathophysiology | 145 | ||
Clinical features | 145 | ||
Incomplete Kawasaki disease | 145 | ||
Differential diagnosis | 145 | ||
Complications | 145 | ||
Investigations | 145 | ||
Treatment | 146 | ||
Refractory Kawasaki disease | 146 | ||
Prognosis | 146 | ||
References | 147 | ||
5.10 Cardiac arrhythmias | 147 | ||
Introduction | 147 | ||
Normal conduction system | 147 | ||
The cardiac action potential | 148 | ||
Vaughan Williams antiarrhythmia drug classification | 148 | ||
Pathogenesis of arrhythmias | 149 | ||
Bradyarrhythmias | 149 | ||
Tachyarrhythmias | 149 | ||
General principles for arrhythmia management | 150 | ||
Bradyarrhythmias | 150 | ||
Sinus bradycardia | 150 | ||
Sinus node dysfunction | 150 | ||
Conduction disturbances: atrioventricularblock | 150 | ||
Bundle branch block | 151 | ||
Tachyarrhythmias | 151 | ||
Wide complex tachyarrhythmia | 151 | ||
Narrow complex tachyarrhythmia | 151 | ||
Wolff–Parkinson–White syndrome | 152 | ||
Atrial flutter | 152 | ||
Atrial fibrillation | 152 | ||
Ventricular fibrillation | 152 | ||
Role of ‘molecular autopsy’ insudden unexplained cardiac death in the young | 152 | ||
Further reading | 153 | ||
6 -\rRESPIRATORY | 155 | ||
6.1 Stridor and noisy breathing \r | 155 | ||
Introduction | 155 | ||
Initial assessment | 155 | ||
History | 155 | ||
Examination | 156 | ||
Common causes of acute stridor in children | 156 | ||
Common causes of chronic stridor in children | 156 | ||
Larynx | 156 | ||
Subglottis | 157 | ||
Trachea | 157 | ||
References | 157 | ||
6.2 Upper respiratory tract infections | 157 | ||
7 - GASTROENTEROLOGY AND HEPATOLOGY | 181 | ||
7.1 Abdominal pain | 181 | ||
Introduction | 181 | ||
Pathophysiology | 182 | ||
Aetiology | 182 | ||
Assessment | 182 | ||
History | 182 | ||
1. The age of the child | 182 | ||
2. Whether this is the first episodeor recurrence of abdominal pain | 183 | ||
3. Whether there are other associated symptoms | 183 | ||
4. Whether there are any relevant pre-existing conditions | 183 | ||
5. What are the characteristics ofthe pain? | 183 | ||
Examination | 183 | ||
Investigations | 183 | ||
Pathology | 183 | ||
Imaging | 184 | ||
Management | 184 | ||
Disposition | 184 | ||
ACUTE APPENDICITIS | 184 | ||
Introduction | 184 | ||
Clinical features | 184 | ||
Differential diagnoses | 184 | ||
8 - NEUROLOGY | 235 | ||
8.1 Cerebrospinal fluid shunt complications | 235 | ||
Introduction | 235 | ||
Types of shunt | 235 | ||
Clinical presentation | 236 | ||
History | 236 | ||
Examination | 236 | ||
Shunt evaluation | 236 | ||
Investigations | 237 | ||
Aspects of some cerebrospinal fluid shunt complications | 237 | ||
Early post-operative complications | 238 | ||
Migration and penetration of shunts | 238 | ||
Glomerulonephritis | 238 | ||
Trauma in children with a cerebrospinal fluid shunt | 238 | ||
References | 238 | ||
8.2 Raised intracranial pressure | 239 | ||
Introduction | 239 | ||
Normal physiology | 239 | ||
Pathophysiology | 239 | ||
Measurement of intracranial pressure | 239 | ||
Particular issues in children | 240 | ||
Infants | 240 | ||
Clinical features of raisedintracranial pressure | 240 | ||
The central herniation syndrome | 240 | ||
The lateral mass herniation syndrome | 240 | ||
Cerebellar tonsillar herniation syndrome | 240 | ||
Other examination findings in raised intracranial pressure | 241 | ||
Fundi | 241 | ||
Peripheral neurological signs | 241 | ||
Investigations | 241 | ||
Management of raised intracranial pressure | 241 | ||
Some particular causes of raised intracranial pressure | 242 | ||
Idiopathic intracranial hypertension (aka pseudotumour cerebri or benign intracranial hypertension) | 242 | ||
Fever and raised intracranial pressure | 242 | ||
References | 242 | ||
8.3 Seizures and non-epileptic events | 243 | ||
Introduction | 243 | ||
General comments | 243 | ||
Classification of seizures | 243 | ||
Febrile seizures | 243 | ||
PRESENTATION TOEMERGENCY DEPARTMENT | 244 | ||
Presentation post a possible seizure | 244 | ||
History | 244 | ||
Examination | 244 | ||
Differential diagnosis and specific seizure syndromes | 244 | ||
Drug therapy | 245 | ||
Investigations | 246 | ||
Disposition | 246 | ||
Acknowledgements | 247 | ||
Further reading | 247 | ||
8.4 Acute weakness | 247 | ||
Introduction | 247 | ||
Presentation | 247 | ||
Trauma masquerading as weakness | 247 | ||
Primary survey approach | 247 | ||
General inspection | 247 | ||
ABC | 247 | ||
DEFG | 248 | ||
History | 248 | ||
Examination | 248 | ||
Investigations | 248 | ||
Laboratory | 248 | ||
Imaging | 249 | ||
Specific conditions causing acute weakness | 249 | ||
Guillain–Barré syndromeIntroduction | 249 | ||
Tick paralysis | 250 | ||
Botulism | 250 | ||
Spinal cord lesions | 251 | ||
Myasthenia gravis | 251 | ||
Poliomyelitis and other enteroviral infections | 252 | ||
Bell’s palsy | 252 | ||
Toxic neuropathies | 252 | ||
Hereditary neuropathy | 253 | ||
Muscular disorders | 253 | ||
Somatisation disorders/malingering | 253 | ||
Acknowledgement | 253 | ||
Further reading | 253 | ||
8.5 Acute ataxia | 254 | ||
Introduction | 254 | ||
Pathophysiology | 254 | ||
Cerebellum | 254 | ||
Cerebral hemispheres and vermis | 254 | ||
Cerebellar peduncles and connections | 254 | ||
Differential diagnosis | 255 | ||
Acute cerebellar ataxia | 255 | ||
Poisoning | 255 | ||
Tumours | 256 | ||
Trauma | 256 | ||
Infections | 256 | ||
Vascular conditions | 256 | ||
Other neurological conditions | 256 | ||
Metabolic disorders | 256 | ||
Chronic ataxia | 256 | ||
Hereditary ataxias/spinocerebellar degenerative | 257 | ||
Congenital malformations | 257 | ||
Clinical evaluation of the patient | 257 | ||
History | 257 | ||
Examination | 257 | ||
Investigations | 257 | ||
Management | 258 | ||
References | 258 | ||
8.6 Headache | 259 | ||
Introduction | 259 | ||
Incidence | 259 | ||
Pathophysiology | 259 | ||
Clinical assessment | 260 | ||
History | 260 | ||
Examination | 260 | ||
Investigation | 261 | ||
Management | 262 | ||
Disposition | 262 | ||
MIGRAINE | 262 | ||
Pathophysiology | 262 | ||
Clinical features | 262 | ||
Investigation | 263 | ||
Treatment | 263 | ||
Disposition | 263 | ||
Conclusions | 263 | ||
References | 263 | ||
8.7 Central nervous system infections: meningitis and encephalitis | 264 | ||
Introduction | 264 | ||
Meningitis | 264 | ||
Classification | 264 | ||
Aetiology | 264 | ||
Clinical findings | 265 | ||
Investigations | 265 | ||
Management | 266 | ||
Prevention | 266 | ||
Complications | 266 | ||
Brain abscess | 267 | ||
Encephalitis | 267 | ||
Aetiology | 267 | ||
Clinical findings | 267 | ||
Investigations | 267 | ||
Management | 267 | ||
Complications | 267 | ||
Conclusion | 267 | ||
References | 267 | ||
9 -\rINFECTIOUS DISEASES | 269 | ||
9.1 Infectious diseases | 269 | ||
Fever | 269 | ||
Defining and measuring temperature | 269 | ||
Fever: to treat or not to treat? | 269 | ||
Practical approach to the febrile child | 270 | ||
Fever with localising signs | 270 | ||
Fever without focus | 270 | ||
Pyrexia of unknown origin | 271 | ||
Empiric antibiotic therapy | 271 | ||
Antimicrobial resistance | 271 | ||
Common infectious exanthems | 271 | ||
What specimens, when should they be ordered and what tests? | 272 | ||
Collection of microbiological specimens | 272 | ||
Blood cultures | 272 | ||
Cerebrospinal fluid | 272 | ||
Urine | 272 | ||
Stool specimens | 273 | ||
Throat swab | 273 | ||
Nasopharyngeal aspirate | 273 | ||
Nasal swab | 273 | ||
Infection control in the emergency department | 273 | ||
Needlestick injury | 273 | ||
The child presenting with a (community) needlestick injury | 273 | ||
Hospital staff exposure to blood-borne viruses | 273 | ||
Immunisation | 273 | ||
Immunisation of staff | 273 | ||
Opportunistic immunisation | 273 | ||
References | 273 | ||
10 - METABOLIC EMERGENCIES | 275 | ||
10.1 Inborn errors of metabolism | 275 | ||
Introduction | 275 | ||
Physiology and pathogenesis | 275 | ||
Clinical features | 275 | ||
Investigation | 276 | ||
Management | 277 | ||
Reduction of toxic compound production | 277 | ||
Removal/enhancement of excretion of toxic compounds | 278 | ||
Chronic presentations | 278 | ||
Extended newborn screening | 278 | ||
Conclusion | 278 | ||
10.2 Hypoglycaemia in the non-diabetic child | 279 | ||
Introduction | 279 | ||
The hypoglycaemia screen | 279 | ||
Causes of hypoglycaemia | 279 | ||
Endocrine and metabolic causes | 279 | ||
Pharmacological and toxic causes | 279 | ||
Treatment of hypoglycaemia | 280 | ||
References | 280 | ||
10.3 Diabetic emergencies in children | 281 | ||
Diagnosis | 281 | ||
Diabetic ketoacidosis | 281 | ||
Resuscitation | 281 | ||
Fluid | 281 | ||
Insulin | 281 | ||
Potassium | 281 | ||
Sodium | 282 | ||
Acidosis and bicarbonate | 282 | ||
Phosphate | 282 | ||
Complications | 282 | ||
Disposition | 282 | ||
Hypoglycaemia | 282 | ||
The child with an insulin pump | 282 | ||
Long-term management | 283 | ||
Further reading | 283 | ||
10.4 Thyroid emergencies | 284 | ||
Thyrotoxicosis | 284 | ||
Clinical features | 284 | ||
Diagnosis | 284 | ||
Treatment | 284 | ||
Neonatal thyrotoxicosis | 284 | ||
Hypothyroidism | 284 | ||
Congenital hypothyroidism | 284 | ||
Hashimoto’s thyroiditis | 285 | ||
Further reading | 285 | ||
10.5 Adrenal emergencies | 285 | ||
ADRENAL CRISIS | 286 | ||
Introduction | 286 | ||
Clinical presentation | 286 | ||
History | 286 | ||
Examination | 286 | ||
Investigations | 286 | ||
Differential diagnosis | 286 | ||
Treatment | 286 | ||
Fluid management | 286 | ||
Replacement of corticosteroid | 286 | ||
Hypoglycaemia | 286 | ||
Hyperkalaemia | 286 | ||
Disposition | 287 | ||
Prevention | 287 | ||
CUSHING’S SYNDROME | 287 | ||
Introduction | 287 | ||
Presenting symptoms | 287 | ||
Diagnostic testing | 287 | ||
Treatment | 287 | ||
Further reading | 288 | ||
10.6 Disorders of fluids, electrolytes and acid–base | 288 | ||
Introduction | 288 | ||
Physiology | 288 | ||
Clinical assessment | 289 | ||
Haemorrhagic shock | 289 | ||
Fluid deficit | 289 | ||
Oedema | 290 | ||
Investigations | 290 | ||
Treatment | 290 | ||
Replacement of circulating volume | 290 | ||
How much fluid? | 291 | ||
How to administer fluid in shock | 291 | ||
Investigation and management of fluids in different conditions | 291 | ||
Dehydration | 291 | ||
Syndrome of inappropriate antidiuretic hormone secretion | 292 | ||
Pyloric stenosis | 292 | ||
Sepsis and meningococcal disease | 293 | ||
Haemorrhagic shock | 293 | ||
Head injury | 293 | ||
Burns (Chapter 4.6) | 293 | ||
Diabetic ketoacidosis (Chapter 10.3) | 293 | ||
Hyperkalaemia | 293 | ||
Hypokalaemia | 293 | ||
Maintenance fluids | 293 | ||
Acid–base disorders | 294 | ||
Metabolic acidosis | 294 | ||
Metabolic alkalosis | 295 | ||
Acknowledgement | 295 | ||
References | 295 | ||
11 - HAEMATOLOGY AND ONCOLOGY | 297 | ||
11.1 The use of blood products in children | 297 | ||
Introduction | 297 | ||
Use of blood products inresuscitation1, 2 | 298 | ||
Packed red blood cells1 | 298 | ||
Recommended initial dose of packed red blood cell transfusion | 298 | ||
Adverse reactions | 298 | ||
Platelets | 298 | ||
Indications | 298 | ||
12 -\rDERMATOLOGY | 327 | ||
12.1 Dermatology | 327 | ||
Introduction | 327 | ||
Management | 327 | ||
Vesiculobullous rashes | 329 | ||
Varicella (chickenpox) (also seeChapter 3.3 Neonatal dermatology) | 329 | ||
Zoster | 329 | ||
Hand, foot and mouth disease | 330 | ||
Herpes simplex infection | 330 | ||
Eczema herpeticum | 330 | ||
Impetigo (School sores) | 331 | ||
Staphylococcal scalded skin syndrome | 331 | ||
Erythema multiforme | 331 | ||
Stevens–Johnson syndrome/toxic epidermal necrolysis | 332 | ||
Dermatitis herpetiformis | 332 | ||
Other immune-mediated blistering disorders | 332 | ||
Sunburn and photosensitivity | 332 | ||
Primary photosensitivity disorders | 333 | ||
Porphyrias and other inherited disorderswith photosensitivity | 333 | ||
Photosensitivity and bullous reactions to drugs | 333 | ||
Photosensitivity reactions to plants | 334 | ||
Contact dermatitis – plants | 334 | ||
Contact dermatitis – id reactions | 334 | ||
Isolated blisters | 334 | ||
Neonatal vesicles (see Chapter 3.3 Neonatal dermatology) | 334 | ||
Pustular rashes | 334 | ||
Acne | 334 | ||
Acne and depression | 335 | ||
Acne fulminans | 335 | ||
Acne with Gram-negative folliculitis | 335 | ||
Folliculitis | 335 | ||
Acute generalised exanthematous pustulosis | 336 | ||
Pustular psoriasis | 336 | ||
Neonatal pustules (see Chapter 3.3 Neonatal dermatology)Neonatal pityrosporum folliculitis (seeChapter 3.3 Neonatal dermatology) | 336 | ||
Papular (raised) rashes | 336 | ||
Scabies | 336 | ||
Papular acrodermatitis of childhood | 337 | ||
Papular urticaria | 337 | ||
Molluscum | 337 | ||
Adnexal tumours – pilomatricoma | 338 | ||
Keratosis pilaris | 338 | ||
Granuloma annulare | 338 | ||
Langerhans cell histiocytosis | 338 | ||
Juvenile xanthogranulomas | 339 | ||
Xanthomas | 339 | ||
Angiofibromas in tuberosclerosis | 339 | ||
Red scaly (papulosquamous) rashes | 339 | ||
Psoriasis | 339 | ||
Tinea corporis | 339 | ||
Pityriasis rosea | 340 | ||
Secondary syphilis | 340 | ||
Seborrhoeic dermatitis | 340 | ||
Lichen striatus | 341 | ||
Eczematous rashes | 341 | ||
Atopic eczema – general issues | 341 | ||
Atopic eczema – general management principles | 341 | ||
Atopic eczema – dietary principles | 342 | ||
Atopic eczema – use of topicalcorticosteroid preparations | 342 | ||
Atopic eczema – acute flare | 342 | ||
Atopic eczema – admission to hospital | 342 | ||
Atopic eczema – generalised infantile | 342 | ||
Atopic eczema – facial | 342 | ||
Atopic eczema – perioral eczema versus juvenile rosacea | 343 | ||
Atopic eczema – periorbital | 343 | ||
Atopic eczema – molluscum | 343 | ||
Atopic eczema – discoid | 343 | ||
Atopic eczema – juvenile plantar dermatosis | 343 | ||
Atopic eczema with systemic associations | 343 | ||
Irritant contact dermatitis | 343 | ||
Allergic contact dermatitis | 343 | ||
Generalised dry skin – ichthyosis | 344 | ||
Generalised dry skin – ectodermal dysplasias | 344 | ||
Red blanching rashes (erythematous) | 344 | ||
Fever and exanthem | 344 | ||
Scarlet fever | 344 | ||
Toxic shock syndrome | 344 | ||
Kawasaki disease | 344 | ||
Erythema infectiosum | 345 | ||
Roseola infantum | 345 | ||
Enteroviruses | 345 | ||
Infectious mononucleosis | 345 | ||
Measles | 345 | ||
Rubella | 346 | ||
Unilateral laterothoracic exanthem | 346 | ||
Urticaria | 346 | ||
Serum sickness | 347 | ||
Lupus erythematosus | 347 | ||
Neonatal lupus erythematosus (see Chapter 3.3 Neonatal dermatology) | 347 | ||
Juvenile chronic arthritis | 347 | ||
Erythema nodosum | 348 | ||
Necrobiosis lipoidica | 348 | ||
Palmoplantar hidradenitis | 348 | ||
Pernio (chilblains) | 348 | ||
Spider telangiectasia | 348 | ||
Other erythematous rashes | 348 | ||
Purpuric rashes | 348 | ||
Fever and petechiae | 348 | ||
Fever and petechiae in an unwell child (including meningococcal sepsis) | 348 | ||
Fever and petechiae in a well child | 349 | ||
Meningococcal sepsis and other septicaemia | 349 | ||
Vasculitis and Henoch–Schönlein purpura | 349 | ||
Thrombocytopenic purpura | 349 | ||
Leukaemia | 349 | ||
Coagulation disorders | 350 | ||
Child abuse | 350 | ||
Artefactual purpura | 350 | ||
Papular-purpuric gloves and socks syndrome | 350 | ||
Dusky purple nodules on hands and feet | 350 | ||
Chronic pigmented purpura | 350 | ||
Other causes of childhood purpura | 350 | ||
Neonatal purpura (see Chapter 3.3 Neonatal dermatology) | 350 | ||
Vascular tumours – haemangiomas and haemangioma variants | 350 | ||
Haemangiomas of infancy | 350 | ||
Rapidly involuting congenital haemangioma | 351 | ||
Kaposiform haemangioendothelioma/tufted angioma | 351 | ||
Pyogenic granuloma | 352 | ||
Vascular malformations | 352 | ||
Neonatal vascular malformations | 352 | ||
Facial capillary malformations (‘port wine stain’) | 352 | ||
High-flow lesions | 352 | ||
Pain, swelling | 352 | ||
Bleeding, coagulopathy | 352 | ||
Chest pain or shortness of breath | 352 | ||
Intestinal bleeding, anaemia | 352 | ||
Bladder or bowel dysfunction in older children | 352 | ||
Leg length discrepancy | 352 | ||
Multiple telangiectatic vessels | 353 | ||
Fabry disease | 353 | ||
Management of vascular malformations | 353 | ||
Hyperpigmentation | 353 | ||
Diffuse hyperpigmentation | 353 | ||
Localised macular hyperpigmentation – including café-au-lait macules | 353 | ||
Presentations with dermal (blue/grey) pigmentation | 354 | ||
Localised raised hyperpigmentation | 354 | ||
Congenital pigmented naevi | 354 | ||
Acquired pigmented naevi | 354 | ||
Dysplastic naevi | 354 | ||
Halo naevi | 354 | ||
Spitz naevi | 355 | ||
Hypopigmentation | 355 | ||
Pityriasis versicolor | 355 | ||
Pityriasis alba | 355 | ||
Vitiligo | 355 | ||
Post-inflammatory hypopigmentation | 355 | ||
Linear and whorled hypopigmention (‘hypomelanosis of Ito’) | 355 | ||
Tuberous sclerosis | 355 | ||
Generalised hypopigmentation | 355 | ||
Skin texture | 355 | ||
Lax skin | 355 | ||
Firm or thickened skin | 355 | ||
Mouth disorders | 355 | ||
Primary herpetic gingivostomatitis | 356 | ||
Herpangina | 356 | ||
Transient lingual papillitis | 356 | ||
Angular cheilitis | 356 | ||
Geographic tongue | 356 | ||
Recurrent mouth ulcers | 356 | ||
Anogenital rashes | 356 | ||
Irritant napkin dermatitis | 357 | ||
Candida napkin dermatitis | 357 | ||
Anogenital psoriasis | 357 | ||
Perianal streptococcal dermatitis | 357 | ||
Staphylococcal-mediated anogenital rashes | 357 | ||
Herpes simplex virus | 357 | ||
Varicella (see p. 327 | 357 | ||
Threadworms | 357 | ||
Lichen sclerosis | 358 | ||
Vulval itch/vulvitis in prepubertal girls | 358 | ||
Zinc and other nutritional deficiencies | 358 | ||
Malabsorption | 358 | ||
Langerhans cell histiocytosis | 358 | ||
Constipation | 358 | ||
Anogenital papules and lumps | 358 | ||
Anogenital warts | 358 | ||
Molluscum | 358 | ||
Congenital syphilis | 358 | ||
Immunodeficiency states | 358 | ||
Hair problems | 358 | ||
Head lice | 358 | ||
Tinea capitis | 359 | ||
Kerion (inflammatory ringworm) | 359 | ||
Alopecia areata | 359 | ||
Traumatic alopecia | 359 | ||
Diffuse hair loss | 359 | ||
Hypertrichosis | 359 | ||
Hirsutism | 360 | ||
Nail problems | 360 | ||
Paronychia | 360 | ||
Nail psoriasis | 360 | ||
Ingrown toenail | 360 | ||
Tinea unguium (onychomycosis) | 360 | ||
Itch without rash | 360 | ||
Collection of specimens | 360 | ||
References | 361 | ||
13 - EYES | 363 | ||
13.1 Ophthalmological emergencies | 363 | ||
Introduction | 363 | ||
History | 363 | ||
Examination | 363 | ||
The red eye in paediatrics | 364 | ||
The red eyelid | 364 | ||
The red eyeball | 365 | ||
13.2 Congenital, developmental and neoplastic conditions of the eye | 367 | ||
DEFICITS IN VISUAL ACUITY | 367 | ||
Strabismus | 367 | ||
Paediatric cataracts | 367 | ||
Congenital nasolacrimal duct obstruction | 367 | ||
Infantile glaucoma | 367 | ||
Ocular tumours | 367 | ||
Retinoblastoma | 367 | ||
Rhabdomyosarcoma | 368 | ||
Neuroblastoma | 368 | ||
Further reading | 368 | ||
13.3 Ocular trauma | 368 | ||
Introduction | 368 | ||
Globe trauma | 369 | ||
Open globe injury (globe rupture and penetrating eye injury) | 370 | ||
Eyelid trauma | 370 | ||
Ecchymosis | 370 | ||
Orbital trauma | 370 | ||
Further reading | 371 | ||
14 - ENT AND DENTAL | 373 | ||
14.1 The ear | 373 | ||
Otitis externa | 373 | ||
Introduction | 373 | ||
History | 373 | ||
Examination | 373 | ||
Investigations | 373 | ||
15 - OBSTETRICS AND GYNAECOLOGY | 389 | ||
15.1 Paediatric gynaecology | 389 | ||
Infant and prepubescent gynaecology | 389 | ||
Vaginal discharge | 389 | ||
Vaginal bleeding | 390 | ||
Labial adhesions | 391 | ||
Distressing vaginal or perineal pain | 391 | ||
Adolescent gynaecology | 391 | ||
Vaginal discharge and sexually transmitted infections | 391 | ||
Abnormal vaginal bleeding | 393 | ||
Pelvic pain | 393 | ||
Acknowledgement | 394 | ||
References | 394 | ||
15.2 Emergency contraception | 395 | ||
Introduction | 395 | ||
Clinical assessment | 395 | ||
Available medicines | 395 | ||
Medicine contraindications | 396 | ||
Medicine adverse effects | 396 | ||
Medicine outcomes | 396 | ||
Copper intrauterine devices | 396 | ||
References | 396 | ||
16 - RENAL | 397 | ||
16.1 Acute kidney injury | 397 | ||
Introduction | 397 | ||
Pathophysiology | 398 | ||
Clinical presentation | 398 | ||
Treatment | 398 | ||
Acute presentation of chronic renal failure | 400 | ||
Acute kidney injury in the renal transplant recipient | 400 | ||
16.2 Haematuria | 401 | ||
Isolated microscopic haematuria | 401 | ||
History | 402 | ||
Examination | 402 | ||
Investigation | 402 | ||
Disposition | 402 | ||
16.3 Hypertension | 403 | ||
Introduction | 403 | ||
History | 403 | ||
Examination | 403 | ||
Emergency department management | 403 | ||
Stage 1 hypertension | 403 | ||
Stage 2 hypertension | 403 | ||
Further reading | 404 | ||
16.4 Urinary tract infection in pre-school children | 404 | ||
Introduction | 404 | ||
History and examination | 404 | ||
Diagnosis | 405 | ||
Treatment | 405 | ||
Prognosis | 406 | ||
Prevention | 406 | ||
11References | 406 | ||
16.5 Haemolytic uraemic syndrome | 407 | ||
Introduction | 407 | ||
Definition of haemolytic uraemic syndrome | 407 | ||
Classification of haemolytic uraemic syndrome | 407 | ||
Pathophysiology of haemolytic uraemic syndrome | 407 | ||
Shiga toxin haemolytic uraemic syndrome | 407 | ||
Pneumococcal-associated haemolytic uraemic syndrome | 408 | ||
Complement-mediated haemolytic uraemic syndrome | 408 | ||
History | 408 | ||
Examination | 408 | ||
Investigations | 408 | ||
Differential diagnosis | 408 | ||
Treatment | 408 | ||
Prognosis | 409 | ||
Complications | 409 | ||
Prevention | 409 | ||
Further reading | 409 | ||
16.6 Idiopathic nephrotic syndrome | 410 | ||
Introduction | 410 | ||
Pathophysiology of proteinuria | 410 | ||
Nephron and glomerular filtration barrier | 410 | ||
Renal handling of albumin | 410 | ||
Mechanisms of proteinuria | 410 | ||
Definition of nephrotic syndrome | 411 | ||
Peripheral oedema AND marked proteinuria* AND hypoalbuminaemia** AND hyperlipidaemia | 411 | ||
Classification of paediatric nephrotic syndrome | 411 | ||
According to cause | 411 | ||
According to renal histology | 412 | ||
According to response to corticosteroids | 412 | ||
Idiopathic nephrotic syndrome: epidemiology | 412 | ||
Minimal change disease | 413 | ||
Primary (idiopathic) focal segmental glomerulosclerosis | 413 | ||
Clinical features of idiopathic nephrotic syndrome | 414 | ||
Oedema | 414 | ||
Other features | 414 | ||
Investigations | 414 | ||
Urine analysis | 414 | ||
Blood tests | 415 | ||
Imaging | 415 | ||
Differential diagnosis | 415 | ||
Complications of idiopathic nephrotic syndrome | 415 | ||
Hypovolaemia | 415 | ||
Infection | 415 | ||
Thrombosis | 416 | ||
Long term due to the nephrotic syndrome or treatment or both | 416 | ||
Treatment of initial nephrotic phase | 416 | ||
General measures | 416 | ||
Immunisation | 417 | ||
Corticosteroid medication | 417 | ||
Oedema | 417 | ||
Proteinuria | 417 | ||
Infection | 417 | ||
Patient with frequent relapses of nephrotic syndrome or persistent nephrotic syndrome | 417 | ||
Prognosis | 418 | ||
Acknowledgements | 418 | ||
Further reading | 418 | ||
16.7 Henoch–Schönlein purpura | 418 | ||
Introduction | 418 | ||
Epidemiology | 418 | ||
Pathogenesis | 418 | ||
Diagnostic criteria for Henoch–Schönlein purpura | 420 | ||
Clinical features | 420 | ||
Rash | 420 | ||
Arthritis | 420 | ||
Gastrointestinal | 420 | ||
Renal | 421 | ||
Other findings | 421 | ||
Diagnosis and investigation | 421 | ||
Initial investigations | 421 | ||
Radiology | 421 | ||
Biopsy | 421 | ||
Differential diagnosis | 421 | ||
Treatment | 422 | ||
Symptomatic | 422 | ||
Complications | 422 | ||
Prevention | 422 | ||
Long-term prognosis and follow-up | 422 | ||
Acknowledgements | 422 | ||
Further reading | 422 | ||
17 - PSYCHIATRIC | 425 | ||
17.1 Paediatric psychiatric emergencies | 425 | ||
Introduction | 425 | ||
General approach | 425 | ||
Assessment | 425 | ||
History | 425 | ||
Collateral history | 425 | ||
Examination | 425 | ||
Investigations | 425 | ||
Synthesis of assessment | 426 | ||
COMMON PAEDIATRIC PSYCHIATRICPRESENTATIONS | 426 | ||
The acutely disturbed child | 426 | ||
Suicidal patients | 426 | ||
Introduction | 426 | ||
Assessment | 426 | ||
Hazards during assessment | 426 | ||
Management following an attempt | 427 | ||
Suicidal patients: important considerations | 427 | ||
Psychosis | 428 | ||
Treatment | 428 | ||
Other psychiatric presentations | 428 | ||
Acute dystonic reactions | 428 | ||
Night terrors | 428 | ||
Acknowledgement | 428 | ||
References | 429 | ||
17.2 The treatment of the behaviourally disturbed adolescent (see Fig. 17.3.4) | 429 | ||
Introduction | 429 | ||
The principles of psychiatric triage | 429 | ||
Purpose | 429 | ||
Time is risk | 429 | ||
Pre-triage | 430 | ||
The hierarchy of needs | 430 | ||
The ABCC of rapid psychiatric assessment | 430 | ||
Arousal | 430 | ||
Behaviour | 430 | ||
Containment | 431 | ||
Cognitive processes | 431 | ||
Managing the ABCC including restraint and acute sedation | 431 | ||
Sedating the adolescent brain | 431 | ||
Signs of organic dysfunction | 432 | ||
Differential diagnosis – medical | 432 | ||
Differential diagnosis – psychiatric | 432 | ||
The management of acute risk including medical risk | 432 | ||
Sentinel nursing observations post intramuscular or intravenous sedation | 433 | ||
Transfer is a potential escalationof risk | 433 | ||
Conclusion | 433 | ||
Further reading | 433 | ||
17.3 Autism and behavioural disturbance in the pre-adolescent child | 434 | ||
Introduction | 434 | ||
Underlying mechanisms in austistic spectrum of disorders/neurodevelopmentaldisorders | 434 | ||
Approach to assessment | 434 | ||
Is sedation necessary? | 434 | ||
Physical examination | 434 | ||
History | 435 | ||
Challenges in emergencydepartment presentations | 435 | ||
Approach to management | 435 | ||
Management | 435 | ||
Acute (Fig. 17.3.4) | 435 | ||
Ongoing management inthe community | 436 | ||
Conclusion | 436 | ||
Further reading | 437 | ||
18 - CRISIS INTERVENTION | 439 | ||
18.1 Sexual assault | 439 | ||
Introduction | 439 | ||
Definitions | 439 | ||
Attitudes/myths surrounding child sexual assault | 439 | ||
Epidemiology of child sexual assault | 440 | ||
Child sexual assault and emergency medicine | 440 | ||
Recognition of child sexual assault | 440 | ||
Signs and symptoms | 440 | ||
Non-specific | 440 | ||
Specific | 440 | ||
Genitoanal anatomy | 440 | ||
Hymen | 440 | ||
Sexually transmitted infections | 440 | ||
Diagnostic considerations | 440 | ||
Role of the emergency physician | 441 | ||
Documentation | 441 | ||
Mandatory reporting legislation | 441 | ||
References | 441 | ||
18.2 Child at risk | 441 | ||
Introduction | 441 | ||
Definition | 442 | ||
Physical abuse | 442 | ||
Neglect | 443 | ||
Medical child abuse | 444 | ||
The community response to the child at risk | 444 | ||
Responsibilities to report | 444 | ||
Legal responsibilities | 444 | ||
What happens after notification? | 444 | ||
Actions based on risk assessment | 444 | ||
Further reading | 444 | ||
19 - ADMINISTRATION IN EMS | 445 | ||
19.1 - Managing the death of a child in the emergency department: Bereavement issues | 445 | ||
The resuscitation process | 446 | ||
Talking to parents and families | 446 | ||
Laying out of the child | 447 | ||
Viewing the body – quiet suite | 447 | ||
The grief response | 447 | ||
Support of the family | 448 | ||
Cultural implications | 448 | ||
Legal issues | 448 | ||
Organ and tissue donation and collection | 448 | ||
Debriefing and support for emergency department staff | 449 | ||
Collaboration with paediatric palliative care services | 449 | ||
The concept of a good death | 449 | ||
Conclusion | 449 | ||
Acknowledgements | 449 | ||
References | 450 | ||
20 - ANALGESIA AND SEDATION | 451 | ||
20.1 Analgesia\r | 451 | ||
Introduction | 451 | ||
Assessment of pain | 451 | ||
Management | 452 | ||
Non-pharmacological methods | 452 | ||
Pharmacological methods | 452 | ||
Oral analgesic agents | 452 | ||
Intranasal or inhaled options | 454 | ||
Methoxyflurane | 454 | ||
Intranasal fentanyl | 454 | ||
Nitrous oxide | 454 | ||
Parenteral analgesics | 454 | ||
Local anaesthetic agents | 454 | ||
Regional anaesthetic techniques | 456 | ||
Chronic pain | 456 | ||
Discharge analgesia | 457 | ||
References | 457 | ||
20.2 Paediatric procedural sedation within the emergency department | 459 | ||
Introduction | 459 | ||
The goal of procedural sedation | 459 | ||
Pre-procedure | 459 | ||
Governance | 459 | ||
Patient selection and risk assessment | 459 | ||
Fasting | 459 | ||
Consent | 459 | ||
Equipment and personnel | 459 | ||
Rapport building | 460 | ||
Intra-procedure | 460 | ||
Post-procedure | 460 | ||
Non-pharmacological methods | 461 | ||
Selection of agents by procedureand age | 461 | ||
Pharmacological methods | 461 | ||
Nitrous oxide | 461 | ||
Ketamine | 462 | ||
Propofol | 462 | ||
Ketafol | 462 | ||
Other agents | 462 | ||
Balanced sedation | 462 | ||
References | 464 | ||
21 -\rPOISONING | 465 | ||
21.1 General approach to poisoning\r | 465 | ||
Introduction and epidemiology | 465 | ||
Diagnosis | 465 | ||
Risk assessment | 466 | ||
Investigations | 466 | ||
Resuscitation | 466 | ||
Decontamination | 466 | ||
Antidotes | 467 | ||
Enhanced elimination | 468 | ||
Supportive care | 468 | ||
Consultation and disposition | 468 | ||
Further reading | 469 | ||
21.2 Specific poisons | 469 | ||
Common poisons | 469 | ||
Paracetamol | 469 | ||
Non-steroidal anti-inflammatory drugs | 470 | ||
Benzodiazepines | 470 | ||
Opioids | 470 | ||
Anticholinergics and antihistamines | 471 | ||
Corrosive ingestions | 471 | ||
Ethanol | 472 | ||
Rare and dangerous poisons | 472 | ||
Salicylates | 472 | ||
β-Blockers | 473 | ||
Calcium-channel blockers | 473 | ||
Digoxin | 473 | ||
Clonidine | 474 | ||
Iron | 474 | ||
Warfarin and rodenticides | 474 | ||
Oral hypoglycaemics | 475 | ||
Tricyclic antidepressants | 475 | ||
Toxic alcohols | 475 | ||
Psychostimulants | 476 | ||
Essential oils | 476 | ||
Organophosphates and carbamates | 476 | ||
House fires | 477 | ||
Acknowledgements | 477 | ||
Further reading | 477 | ||
22 - ENVIRONMENTAL | 479 | ||
22.1 Envenomation | 479 | ||
23 - ULTRASOUND | 513 | ||
23.1 Ultrasound | 513 | ||
References | 515 | ||
23.2 Diagnostic ultrasound in paediatric emergency medicine | 516 | ||
References | 517 | ||
24 - COMMON PROCEDURES | 525 | ||
24.1 - Estimating the weight of infants and children | 525 | ||
Background | 525 | ||
Age-based tools to estimate body weight | 525 | ||
Best guess formula | 525 | ||
Length- and body-habitus–based tools | 525 | ||
Tips | 525 | ||
References | 526 | ||
24.2 Basic airway management techniques | 526 | ||
Background | 526 | ||
OropharYngeal and Nasopharyngeal Airways | 526 | ||
Indications | 526 | ||
Contraindications | 527 | ||
25 - ORTHOPAEDICS AND RHEUMATOLOGY | 575 | ||
25.1 Orthopaedics and rheumatology | 575 | ||
Introduction | 575 | ||
The child with acute musculoskeletal pain or dysfunction | 575 | ||
General approach | 575 | ||
Assessment | 575 | ||
Generalised or multifocal bone/joint pain | 577 | ||
Introduction | 577 | ||
History | 577 | ||
Examination | 577 | ||
Investigations | 577 | ||
Specific conditions | 578 | ||
Macrophage activation syndrome (haemophagocyticlymphohistiocytosis) | 578 | ||
Urticaria and serum sickness | 578 | ||
Henoch–Schönlein purpura | 578 | ||
Rheumatic fever | 579 | ||
Post-streptococcal and other post-infective immune-mediated reactive arthritides | 580 | ||
Neoplastic presentations | 580 | ||
Other important subacute paediatric musculoskeletal presentations | 580 | ||
Traction apophysitis | 580 | ||
Torticollis | 580 | ||
Conclusion | 581 | ||
Acknowledgement | 581 | ||
References | 581 | ||
25.2 C Child with a limp | 581 | ||
Introduction | 581 | ||
History | 582 | ||
Examination | 583 | ||
Investigation | 583 | ||
Clinical decision making in a child with a limp | 583 | ||
Specific conditions | 584 | ||
Transient synovitis | 584 | ||
Acknowledgement | 589 | ||
References | 589 | ||
26 -\rMALE GENITALIA | 603 | ||
26.1 Male genitalia\r | 603 | ||
The acute scrotum | 603 | ||
Introduction | 603 | ||
Torsion of a testicular or epididymal appendage | 603 | ||
Torsion of the testis | 603 | ||
Epididymo-orchitis | 604 | ||
Idiopathic scrotal oedema | 604 | ||
Testicular tumours | 604 | ||
Irreducible inguinal hernia | 604 | ||
Rupture of the testis | 604 | ||
Acute hydrocele | 604 | ||
Acute problems of the penis and foreskin | 604 | ||
Introduction | 604 | ||
Phimosis of the foreskin | 604 | ||
Balanitis | 604 | ||
Paraphimosis | 605 | ||
Priapism | 605 | ||
References | 605 | ||
27 -\rTRANSPORT ANDRETRIEVAL | 607 | ||
27.1 Paediatric emergency retrieval | 607 | ||
Paediatric retrieval | 607 | ||
What’s different about children? | 607 | ||
Paediatric emergency referrals | 607 | ||
Paediatric referral and retrieval – roles and expectations | 608 | ||
The referrer | 608 | ||
The coordinator/administrator | 608 | ||
The paediatric retrieval specialist | 608 | ||
The paediatric emergency transport team | 608 | ||
Paediatric retrieval staff | 608 | ||
Paediatric retrieval equipment | 608 | ||
Criteria for transport | 609 | ||
Degrees of urgency | 609 | ||
Definitions | 610 | ||
Transport platforms | 610 | ||
Road ambulance | 610 | ||
Rotary wing aircraft | 610 | ||
Fixed-wing aircraft | 610 | ||
Weather | 610 | ||
While waiting | 610 | ||
Stabilisation | 611 | ||
Communication and retrieval leadership | 611 | ||
Framework for communications during paediatric retrieval | 611 | ||
Interface with adult retrieval | 611 | ||
Parents | 611 | ||
Paediatric retrieval and end-of-life situations | 612 | ||
Quality | 612 | ||
Summary | 612 | ||
References | 612 | ||
Further Reading | 612 | ||
27.2 Sick child in a rural hospital | 613 | ||
Introduction | 613 | ||
Challenges in the rural setting | 613 | ||
Income | 613 | ||
Housing | 613 | ||
Education | 613 | ||
Culture | 613 | ||
The illnesses | 613 | ||
Birth history | 613 | ||
Trauma | 613 | ||
Infection and diet | 613 | ||
The health services | 613 | ||
Caring for the critically ill child | 614 | ||
Decisions to consider when child presents with an emergency | 614 | ||
Coordination of a resuscitation team prior to the child’s arrival | 614 | ||
Potential problems in the stabilisation of the child | 614 | ||
What can be done to assist care in remote environments? | 614 | ||
Personnel | 614 | ||
Education | 614 | ||
Content of training | 614 | ||
Consultation support | 614 | ||
Transport | 615 | ||
Management protocols | 615 | ||
Hospital facilities | 615 | ||
Relations between rural and urban hospitals | 615 | ||
Acknowledgement | 615 | ||
Further reading | 615 | ||
28 -\rTEACHING PAEDIATRICEMERGENCY MEDICINE | 617 | ||
28.1 Availing web-based resources\r | 617 | ||
Accessing web-based resources | 617 | ||
Needs of paediatric emergency medicine staff | 617 | ||
Educational tools available online | 617 | ||
Social media | 618 | ||
Pitfalls of online content | 618 | ||
Links | 618 | ||
References | 618 | ||
Conflict of interest | 618 | ||
28.2 Teaching paediatric emergency medicine | 619 | ||
Introduction | 619 | ||
Desirable attitudes in paediatric emergency medicine | 619 | ||
Humility | 619 | ||
Caring | 619 | ||
Empathy and compassion | 619 | ||
Non-judgemental approach | 619 | ||
Honesty and integrity | 619 | ||
Advocacy and healthy paternalism | 619 | ||
Self-monitoring and awareness of cognitive errors | 620 | ||
Skill set for paedicatric emergency | 620 | ||
Effective communication | 620 | ||
Skilful clinical examination | 620 | ||
Mastering procedural skills | 620 | ||
Learning to teach | 620 | ||
Self-preservation | 620 | ||
Putting knowledge into perspective | 621 | ||
Learning resources | 621 | ||
People | 621 | ||
Books | 621 | ||
Other media | 621 | ||
Conclusions | 622 | ||
Further reading | 622 | ||
29 -\rPAEDIATRIC RESEARCHIN THE EMERGENCYDEPARTMENT | 623 | ||
29.1 - Research in children in the emergency department | 623 | ||
Research science | 623 | ||
Research question | 623 | ||
Literature review | 624 | ||
Types of studies | 624 | ||
The ethics of medical research | 624 | ||
Key principles | 624 | ||
Ethics of research involving children | 624 | ||
Ethics review process | 626 | ||
The practice and governance of research | 626 | ||
Research documents | 626 | ||
Research protocol | 626 | ||
Case report forms | 626 | ||
Patient information statement and consent form | 627 | ||
Study document file | 627 | ||
The research team | 627 | ||
Databases and analysis | 627 | ||
Reporting guidelines | 627 | ||
Key regulatory documents | 627 | ||
International Conference on Harmonisation of Good Clinical Practice guidelines (ICH-GCP) 12 | 627 | ||
National- and state-based regulations | 627 | ||
Project registration | 627 | ||
Privacy and confidentiality | 627 | ||
Implementation research: an emerging research field | 627 | ||
Multicentre research | 628 | ||
Funding research | 628 | ||
References | 628 | ||
30 - ADOLESCENT MEDICINEIN THE EMERGENCYDEPARTMENT\r | 631 | ||
30.1 - Adolescent medicine in the emergency department | 631 | ||
Introduction | 631 | ||
Adolescent health problems in the emergency department | 631 | ||
The approach to the adolescent in the emergency department | 632 | ||
Establishing rapport | 632 | ||
Seeing adolescents alone | 632 | ||
Psychosocial screening | 632 | ||
Using the HEADSSS framework | 633 | ||
Confidentiality | 633 | ||
The mature minor principle | 633 | ||
Physical examination | 633 | ||
Linking adolescents with community follow-up | 633 | ||
Summary | 633 | ||
References | 634 | ||
30.2 Eating disorders and anorexia | 635 | ||
Introduction | 635 | ||
History | 635 | ||
Examination | 635 | ||
Investigations | 635 | ||
Complications | 635 | ||
Differential diagnosis | 636 | ||
Management | 636 | ||
Prognosis | 637 | ||
References | 637 | ||
Index | 639 | ||
A | 639 | ||
B | 640 | ||
C | 641 | ||
D | 642 | ||
E | 643 | ||
F | 644 | ||
G | 644 | ||
H | 645 | ||
I | 646 | ||
J | 646 | ||
K | 646 | ||
L | 646 | ||
M | 647 | ||
N | 647 | ||
O | 648 | ||
P | 649 | ||
Q | 650 | ||
R | 650 | ||
S | 650 | ||
T | 652 | ||
U | 653 | ||
V | 653 | ||
W | 653 | ||
X | 653 | ||
Y | 653 | ||
Z | 653 |